Try our Advanced Search for more refined results
Intellectual Property
-
March 28, 2025
Failed Software Secrets Case Costs MasterCard Unit $2.8M
A federal judge in Utah has ordered a MasterCard unit to cough up over $2.8 million in legal fees for "aggressively" litigating an "objectively specious" trade secrets suit against two McKinsey consultants who went on to found one of MasterCard's only serious rivals in a corner of the business analytics software market.
-
March 28, 2025
AIG Trade Secrets Row With Insurance Startup Gets Trimmed
A New Jersey federal court narrowed a trade secrets theft suit brought by AIG units against a new insurer founded by former senior executives, calling claims of interference with contract, breach of fiduciary duty and unauthorized access of AIG's computers unsupported Friday.
-
March 28, 2025
Chinese Pool Parts Supplier Can't Undo False Ads Verdict
A Chinese pool parts supplier can't reverse a jury verdict for false advertising and deceptive business practices, a North Carolina federal judge has said, finding the company tried to bring new arguments that weren't raised at trial.
-
March 28, 2025
Fashion Groups Urge Justices To Hear Discovery Rule Fight
Fashion trade associations have thrown their support behind a shoe designer who wants the U.S. Supreme Court to review her appeal of a Second Circuit decision reviving a photography studio's copyright infringement suit, saying there needs to be more predictability in copyright law.
-
March 28, 2025
9th Circ. Affirms Toss Of 3D Printer Co. Derivative Suit
The Ninth Circuit on Friday affirmed the dismissal of a derivative suit brought by a venture capital firm over an $11 million investment it made in a 3D printing company, with the panel finding the lower court correctly tossed the suit due to previous and ongoing "outside entanglements" between the parties.
-
March 28, 2025
NC Atty Can't Shield Bank Docs From Tycoon In Hacking Suit
A North Carolina attorney and former FBI agent can't stop aviation tycoon Farhad Azima from parsing through his bank records as part of an international hacking conspiracy case, a federal judge said Friday, though he did limit the scope of the records Azima sought.
-
March 28, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.
-
March 28, 2025
Fed. Circ. Upholds Janssen's Patent Case Win Over Mylan
The Federal Circuit declined on Friday to undo a lower court ruling that kept Mylan Laboratories Ltd. from releasing a generic version of Janssen Pharmaceuticals Inc.'s schizophrenia drug Invega Trinza, rejecting Mylan's challenge to a finding that the generic drug would cause physicians to infringe a patent covering its dosing regimen.
-
March 28, 2025
CureVac RNA Vax Patent Survives BioNTech's EU Challenge
CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.
-
March 28, 2025
NC Biz Court Bulletin: TikTok Duel Heats Up, NIL Suit Plays On
In March, the North Carolina Business Court readied for trial in an insurance coverage dispute involving Smithfield Foods, heard why TikTok is subject to the state's jurisdiction, and allowed the Cardiac Pack's NIL suit against the NCAA to proceed while a parallel case plays out.
-
March 27, 2025
X Says It Doesn't Owe Rivals 'Free Ride' In Data Scraping Row
X Corp. urged a California federal judge on Thursday to dismiss antitrust counterclaims brought by data-scraping firm Bright Data Ltd. alleging the social media giant improperly imposes unfavorable contract terms to block competitors from taking its data, arguing it doesn't have to let rivals "free ride" on its platform.
-
March 27, 2025
New Procedures Expected To Result In More PTAB Denials
Under new procedures where the director of the U.S. Patent and Trademark Office will decide whether petitions challenging patents should be denied for discretionary reasons, such denials will likely increase, although the policy leaves many unanswered questions, attorneys say.
-
March 27, 2025
Fed. Circ. Orders New Trial In Roland Drum Kit Patent Dispute
The Federal Circuit says a jury in Miami will have to take another look at a nearly decadelong fight over electric drumming patents, deciding on Thursday to wipe out the entirety of a $4.6 million verdict the Japanese audio tech giant Roland Corp. won against a U.S.-based rival.
-
March 27, 2025
Dua Lipa Beats Claim 'Levitating' Ripped Off 1979 Disco Song
Grammy-winning singer Dua Lipa's chart-topping song "Levitating" did not infringe a 1979 disco song, a New York federal judge ruled Thursday, saying a combination of a descending chord progression and musical note in the older work wasn't protectable under copyright law.
-
March 27, 2025
Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP
The Federal Circuit on Thursday revived medical technology company Recor Medical's challenge to a Medtronic Ireland Manufacturing patent on a way to treat heart and renal failure, telling the Patent Trial and Appeal Board to once again review the fight.
-
March 27, 2025
Mercedes Scores USPTO Review Of PTAB Loss
The acting U.S. Patent and Trademark Office director wants a review of an administrative patent board ruling that rejected Mercedes-Benz's efforts to invalidate a processor patent issued over a decade ago to engineers at Intel and later assigned to a company that's asserting it against automakers and others.
-
March 27, 2025
Fitch Even Sues Ex-IP Client In Effort To End Malpractice Case
Fitch Even Tabin & Flannery LLP has launched a lawsuit asking an Illinois federal court to declare that the co-founder of a former client isn't the inventor behind a prenatal test patent, which the firm said would put a stop to a malpractice case against it in state court.
-
March 27, 2025
Oura Gets Samsung's Preemptive IP Strike Tossed, For Now
Samsung Electronics cannot yet seek a declaration that its Galaxy Ring brand of wearable, health-tracking devices does not infringe Oura Health's smart ring patents, a California federal judge ruled Thursday, saying Samsung hasn't shown the Finnish company is threatening to sue for infringement.
-
March 27, 2025
WordPerfect Software Co. Settles 'Alludo' TM Suit In Wash.
The company behind the 1990s word-processing application WordPerfect has settled a Washington-based education technology firm's lawsuit accusing it of stealing a trademarked name for a 2022 revamp, ending the case ahead of an early April trial date in Seattle federal court.
-
March 27, 2025
Pfizer Tops Pharma Tax Avoidance, Senate Dems Say
Pharmaceutical giant Pfizer had no taxable profits in its largest market, the U.S., after booking all its income in jurisdictions including Puerto Rico, Singapore and Ireland, according to a Senate Finance Committee report prepared by panel Democrats that was released Thursday.
-
March 27, 2025
Palo Alto Networks Dodges $100M Cybersecurity Patent Case
A California federal judge has found that Silicon Valley-based Palo Alto Networks Inc. didn't infringe a trio of cybersecurity patents, freeing the company from a lawsuit that had asked for at least $100 million.
-
March 27, 2025
Disney Seeks $5.7M Atty Fee Award After 'Moana' IP Trial Win
The Walt Disney Co. sought $5.7 million in attorney fees Tuesday after beating an animator's trade secret and copyright suit claiming it ripped off his Polynesian adventure story to create "Moana," arguing he engaged in bad-faith tactics like forging evidence, perjuring himself and improperly inflating purported damages.
-
March 27, 2025
Texas IP Attys Get $60K Sanction For Unauthorized Practice
A San Francisco federal magistrate judge has leveled more than $60,000 in personal sanctions against Texas intellectual property lawyer William Ramey III and two other attorneys from his high-volume patent firm, saying two of them practiced law without a California license in numerous cases to escape paying out-of-state admission fees of $328 per lawyer.
-
March 27, 2025
Fox Rothschild Brings On McCarter & English IP Ace In NJ
Fox Rothschild LLP grew its Princeton, New Jersey, office this week with the addition of an intellectual property partner from McCarter & English LLP specializing in patent prosecution for medical devices, technology-enabled hardware and more.
-
March 27, 2025
Life Sciences REIT Says Ex-Employee Stole Trade Secrets
Alexandria Real Estate Equities Inc. filed suit against a former employee in Massachusetts federal court, alleging that he stole a trove of proprietary information as he was planning to leave the company.
Expert Analysis
-
Takeaways From Oral Argument In High Court Trademark Case
Unpacking oral arguments from Dewberry Group v. Dewberry Engineers, which the U.S. Supreme Court is expected to rule on this year, sheds light on the ways in which the decision could significantly affect trademark infringement plaintiffs' ability to receive monetary damages, say attorneys at Buchanan Ingersoll.
-
In-House Counsel Pointers For Preserving Atty-Client Privilege
Several recent rulings illustrate the challenges in-house counsel can face when attempting to preserve attorney-client privilege, but a few best practices can help safeguard communications and effectively assert the privilege in an increasingly scrutinized corporate environment, says Daniel Garrie at Law & Forensics.
-
Improving Comms Between Trial Attys And Tech Witnesses
In major litigation involving complex technology, attorneys should employ certain strategies to collaborate with companies' technical personnel more effectively to enhance both the attorney's understanding of the subject matter and the expert's ability to provide effective testimony in court, say attorneys at Buchalter.
-
Navigating Title IX Compliance In The NIL Era
As universities push to move more name, image and likeness activity in-house, it's unclear how the NCAA and its members will square implementation of the House settlement with Title IX requirements, say attorneys at Buchanan Ingersoll.
-
Series
Collecting Rare Books Makes Me A Better Lawyer
My collection of rare books includes several written or owned by prominent lawyers from early U.S. history, and immersing myself in their stories helps me feel a deeper connection to my legal practice and its purpose, says Douglas Brown at Manatt Health.
-
DeepSeek AI Investigation Could Lead To IP Law Precedents
The investigation by OpenAI and Microsoft into DeepSeek's artificial intelligence model raises interesting legal concerns involving intellectual property and contract law, including potential trade secret appropriation and fair use questions, say Saishruti Mutneja and Raghav Gurbaxani.
-
Opinion
New DOJ Leaders Should Curb Ill-Conceived Prosecutions
First-of-their-kind cases have seemingly led to a string of overly aggressive prosecutions in recent years, so newly sworn-in leaders of the U.S. Department of Justice should consider creating reporting channels to stop unwise prosecutions before they snowball, says Jonathan Porter at Husch Blackwell.
-
Opinion
Judge Should Not Have Been Reprimanded For Alito Essay
Senior U.S. District Judge Michael Ponsor's New York Times essay critiquing Supreme Court Justice Samuel Alito for potential ethical violations absolutely cannot be construed as conduct prejudicial to the administration of the business of the courts, says Ashley London at the Thomas R. Kline School of Law of Duquesne University.
-
A Look At Drug Price Negotiation Program's Ongoing Impact
More than two years after the passage of the Inflation Reduction Act and the rapid implementation of the drug price negotiation program, attorneys at Ropes & Gray discuss how the IRA has influenced licensing strategies, and how maximum fair prices under the law have economically affected certain drugs.
-
Opinion
Congress Must Consider Accurate Data About Patent Thickets
If Congress revisits a controversial bill this year aimed at limiting the number of patents pharmaceutical manufacturers could assert, it must make sure to act based on accurate reports — such as a recent U.S. Patent and Trademark Office study that found no evidence of patent thicketing, says David Kappos at the Council for Innovation Promotion.
-
Lights, Camera, Ethics? TV Lawyers Tend To Set Bad Example
Though fictional movies and television shows portraying lawyers are fun to watch, Hollywood’s inaccurate depictions of legal ethics can desensitize attorneys to ethics violations and lead real-life clients to believe that good lawyers take a scorched-earth approach, says Nancy Rapoport at the University of Nevada, Las Vegas.
-
Opinion
DOGE Should Address Inefficiency In The Patent Marketplace
Elon Musk's Department of Government Efficiency is well positioned to identify to Congress the necessary variability needed among individual patent rights, ensuring that the U.S. Patent and Trademark Office's current inefficiencies do not impede promising inventions from reaching the market, says John Powers at Powers IP.
-
Perspectives
Accountant-Owned Law Firms Could Blur Ethical Lines
KPMG’s recent application to open a legal practice in Arizona represents the first overture by an accounting firm to take advantage of the state’s relaxed law firm ownership rules, but enforcing and supervising the practice of law by nonattorneys could prove particularly challenging, says Seth Laver at Goldberg Segalla.
-
AI Will Soon Transform The E-Discovery Industrial Complex
Todd Itami at Covington discusses how generative artificial intelligence will reshape the current e-discovery paradigm, replacing the blunt instrument of data handling with a laser scalpel of fully integrated enterprise solutions — after first making e-discovery processes technically and legally harder.
-
IP, Licensing, M&A Trends To Watch In Life Sciences This Year
2025 promises to continue an exciting trajectory for the life sciences industry, with major trends ranging from global harmonization of intellectual property to cross-border licensing activity and an increase of nontraditional financial participants in the mergers and acquisition space, say attorneys at Morgan Lewis.